Medroxyprogesterone 17-acetate, Progesterone receptor agonist

Be the first to review this product! Submit a review

|

(2 Publications)

MW 386.5 Da, Purity >99%. Angiostatic steroid. Inhibit vascularization, collagenolysis, tumor growth and plasmin generation. Synthetic variant of progesterone, and a potent progesterone receptor agonist. Active in vitro and in vivo.

View Alternative Names

17-beta-HSD 5, 17-beta-hydroxysteroid dehydrogenase type 5, 2-dihydrobenzene-1, 2-diol dehydrogenase, 20 alpha (3 alpha) hydroxysteroid dehydrogenase, 20-alpha-HSD, 20-alpha-hydroxysteroid dehydrogenase, 2ALPHAHSD, 3 alpha hydroxysteroid dehydrogenase type II, 3 alpha hydroxysteroid dehydrogenase type III, 3-alpha-HSD type 2, 3-alpha-HSD type II, 3-alpha-HSD type II, brain, 3-alpha-HSD3, 3-alpha-hydroxysteroid dehydrogenase type 2, ABP, AIS, AK1C1_HUMAN, AK1C2_HUMAN, AK1C3_HUMAN, AKR1C pseudo, AKR1C1, AKR1C2, ANDR_HUMAN, AR, AR8, Akr1c18, Aldo-keto reductase family 1 member C1, Aldo-keto reductase family 1 member C2, Aldo-keto reductase family 1 member C3, Aldo-keto reductase family, 1 member 1, Aldosterone receptor, Androgen binding protein, Androgen nuclear receptor variant 2, Androgen receptor, Androgen receptor (dihydrotestosterone receptor; testicular feminization; spinal and bulbar muscular atrophy; Kennedy disease), Atherosclerosis, susceptibility to, included, BABP, BXR, Bile acid binding protein, C9, Chlordecone reductase, Chlordecone reductase homolog, Chlordecone reductase homolog HAKRC, Chlordecone reductase homolog HAKRD, Chlordecone reductase homolog HAKRb, DD, DD-2, DD-3, DD/BABP, DD1, DD1/DD2, DDH, DDH 2, DDH1, DDX, DHTR, DKFZp686N23123, Dihydro testosterone receptor, Dihydrodiol dehydrogenase 1, Dihydrodiol dehydrogenase 1/2, Dihydrodiol dehydrogenase 2, Dihydrodiol dehydrogenase 3, Dihydrodiol dehydrogenase X, Dihydrodiol dehydrogenase type I, Dihydrodiol dehydrogenase, type 1, Dihydrodiol dehydrogenase/bile acid-binding protein, Dihydrotestosterone receptor (DHTR), ER, ER-alpha, ER-beta, ER[a], ER[b], ESR, ESR B, ESR BETA, ESR1_HUMAN, ESR2_HUMAN, ESRA, ESTR B, Era, Erb, Erb2, Estr, Estra, Estradiol Receptor alpha, Estradiol Receptor beta, Estradiol receptor, Estrogen Receptor 1, Estrogen Receptor 2, Estrogen receptor, Estrogen receptor 1 (alpha), Estrogen receptor 2 (ER beta), Estrogen receptor 2 ER beta, Estrogen receptor alpha, Estrogen receptor beta, Estrogen receptor beta 4, Estrogen resistance, included, FLJ53800, GCCR, GCRST, GCR_HUMAN, GR, Glucocorticoid receptor, Grl1, H37, HA1753, HAKRB, HAKRC, HAKRD, HAKRe, HBAB, HDL cholesterol, augmented response of, to hormone replacement, included, HSD17B5, HUMARA, HYSP1, Hepatic dihydrodiol dehydrogenase, High-affinity hepatic bile acid-binding protein, Indanol dehydrogenase, KD, KIAA0119, Kennedy disease (KD), MBAB, MCDR 2, MCR_HUMAN, MGC133092, MGC8954, MLR, MR, Mineralocorticoid receptor, Myocardial infarction, susceptibility to, included, NF-E2-related factor 2, NF2L2_HUMAN, NR1I2_HUMAN, NR3 C2, NR3A1, NR3A2, NR3C2 protein, NR3C3, NR3C4, NRF2, Nfe2l2, Nuclear factor, Nuclear factor (erythroid derived 2) like 2, Nuclear factor erythroid 2-related factor 2, Nuclear factor erythroid derived 2 like 2, Nuclear receptor subfamily 1 group I member 2, Nuclear receptor subfamily 3 group A member 1, Nuclear receptor subfamily 3 group A member 2, Nuclear receptor subfamily 3 group C member 1, Nuclear receptor subfamily 3 group C member 2, Nuclear receptor subfamily 3 group C member 3, Nuclear receptor subfamily 3 group C member 4, Nuclear receptor subfamily 3 group C member 4 (NR3C4), ONR 1, OTTHUMP00000017718, OTTHUMP00000017719, OTTHUMP00000044759, OTTHUMP00000215173, OTTHUMP00000215174, OTTHUMP00000215175, Orphan nuclear receptor PAR 1, Orphan nuclear receptor PXR, PAR, PAR q, PGFS, PGR, PR, PRA, PRB, PRGR_HUMAN, PRR, Pregnane X receptor, Progesterone receptor, Progestin receptor form A, Progestin receptor form B, Prostaglandin F synthase, Pseudo chlordecone reductase, RNESTROR, SBMA, SBP, SHBG_HUMAN, SMAX1, SRXY8, SXR, Sex hormone-binding globulin, Sex steroid-binding protein, Spinal and bulbar muscular atrophy, Spinal and bulbar muscular atrophy (SBMA), Steroid and xenobiotic receptor, TFM, TeBG, Testicular Feminization (TFM), Testis-specific androgen-binding protein, Testosterone 17-beta-dehydrogenase 5, Testosterone binding beta globulin, Testosterone-estradiol-binding globulin, Testosterone-estrogen-binding globulin, Trans-1, Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase, Type II 3 alpha hydroxysteroid dehydrogenase, Type II dihydrodiol dehydrogenase, Type III 3-alpha-hydroxysteroid dehydrogenase, Type IIb 3 alpha hydroxysteroid dehydrogenase, aldo-keto reductase C, androgen receptor splice variant 4b, dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase, dihydrodiol dehydrogenase isoform DD1, erythroid derived 2, estrogen nuclear receptor beta variant a, estrogen nuclear receptor beta variant b, glucocorticoid nuclear receptor variant 1, hluPGFS, like 2, nr3c1, nuclear factor erythroid 2 like 2, nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor), pregnane X nuclear receptor variant 2